Hygiene, microbial diversity and immune regulation

Current Opinion in Gastroenterology

Volumn 23, Issue 6, 2007, Pages 667-672

  Guarner, Francisco ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Allergy; Asthma; IBD; Microbiota; Regulatory T cells

Indexed keywords

CYTOKINE;

ALLERGIC DISEASE; ASTHMA; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE; COMMENSAL; ENDOTOXIN DETECTION; ENTERITIS; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; GUT MICROECOSYSTEM; HUMAN; HYGIENE; IMMUNE DYSREGULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LIFESTYLE MODIFICATION; MICROBIAL DIVERSITY; MICROFLORA; MULTIPLE SCLEROSIS; PREVALENCE; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; RURAL AREA; URBAN AREA;

ASTHMA; FECES; HUMANS; HYGIENE; HYPERSENSITIVITY, IMMEDIATE; INFECTION; INFLAMMATORY BOWEL DISEASES; LIFE STYLE; SANITATION;

EID: 34848856098     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3282eeb43b     Document Type: Review

References (59)

1. Koplan JP. I've got a little list. BMJ 2007; 334 (Suppl 1):s20.
2. Mackenbach JP. Sanitation: pragmatism works. BMJ 2007; 334 (Suppl 1):s17. The authors provide interesting comments on the origin of the first regulatory measures to provide sanitation in cities from England and Wales.
3. Burns H. Germ theory: invisible killers revealed. BMJ 2007; 334 (Suppl 1):s11.
4. Rook GA, Brunet LR. Give us this day our daily germs. Biologist (London) 2002; 49:145-149.
5. Guarner F, Bourdet-Sicard R, Brandtzaeg P, et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 2006; 3:275-284. The gut is a principal scenario for immune regulation in the intestinal mucosa and beyond.
6. Dorevitch S, Tharenos L, Demirtas H, et al. Inverse association between rural environment in infancy and sensitization to rodents in adulthood. Ann Allergy Asthma Immunol 2007; 98:440-446.
7. Zeyrek CD, Zeyrek F, Sevinc E, Demir E. Prevalence of asthma and allergic diseases in Sanliurfa, Turkey, and the relation to environmental and socioeconomic factors: is the hygiene hypothesis enough? J Investig Allergol Clin Immunol 2006; 16:290-295.
8. Seiskari T, Kondrashova A, Viskari H, et al., The EPIVIR study group. Allergic sensitization and microbial load - a comparison between Finland and Russian Karelia. Clin Exp Immunol 2007; 148:47-52.
9. Kinra S, Davey Smith G, Jeffreys M, et al. Association between sibship size and allergic diseases in the Glasgow Alumni Study. Thorax 2006; 61:48-53. This splendid investigation was based on alumni surveys performed 40-60 years ago.
10. Goldberg S, Israeli E, Schwartz S, et al. Asthma prevalence, family size and birth order. Chest 2007; 131:1747-1752.
11. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006; 101:993-1002.
12. Ponsonby AL, van der Mei I, Dwyer T, et al. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 2005; 293:463-469.
13. Sadovnick AD, Yee IM, Ebers GC, Canadian Collaborative Study Group. Multiple sclerosis and birth order: a longitudinal cohort study. Lancet Neurol 2005; 4:611-617.
14. Nickmilder M, Carbonnelle S, Bernard A. House cleaning with chlorine bleach and the risks of allergic and respiratory diseases in children. Pediatr Allergy Immunol 2007; 18:27-35.
15. Perzanowski MS, Miller RL, Thorne PS, et al. Endotoxin in inner-city homes: associations with wheeze and eczema in early childhood. J Allergy Clin Immunol 2006; 117:1082-1089.
16. Bach JF. Infections and autoimmune diseases. J Autoimmun 2005; 25 (Suppl):74-80. This is a very interesting discussion on the dual role of infections in preventing and precipitating autoimmunity.
17. Ryozawa M, Matsubara T, Ichiyama T, et al. Clinical sepsis in neonates is responsible for the lower prevalence of developing allergy. Pediatr Int 2007; 49:15-18.
18. Zutavern A, von Klot S, Gehring U, et al. Prenatal and postnatal exposure to respiratory infection and atopic diseases development: a historical cohort study. Respir Res 2006; 7:81.
19. Friedlander SL, Jackson DJ, Gangnon RE, et al. Viral infections, cytokine dysregulation and the origins of childhood asthma and allergic diseases. Pediatr Infect Dis J 2005; 24 (11 Suppl):S170-S176.
20. Hagerhed-Engman L, Bornehag CG, Sundell J, Aberg N. Day-care attendance and increased risk for respiratory and allergic symptoms in preschool age. Allergy 2006; 61:447-453.
21. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br J Dermatol 2005; 152:202-216.
22. Green C, Elliott L, Beaudoin C, Bernstein CN. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 2006; 164:615-623.
23. Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006; 12:925-933.
24. Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130:1588-1594.
25. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124:837-848. Key review describing the symbiotic relationship between the microbial ecosystem in the gut and the host.
26. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-1638.
27. Debley JS, Smith JM, Redding GJ, Critchlow CW. Childhood asthma hospitalization risk after cesarean delivery in former term and premature infants. Ann Allergy Asthma Immunol 2005; 94:228-233.
28. Juhn YJ, Weaver A, Katusic S, Yunginger J. Mode of delivery at birth and development of asthma: a population-based cohort study. J Allergy Clin Immunol 2005; 116:510-516.
29. Bjorksten B. Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Semin Immunopathol 2004; 25:257-270.
30. Murray CS, Tannock GW, Simon MA, et al. Fecal microbiota in sensitized wheezy and nonsensitized nonwheezy children: a nested case-control study. Clin Exp Allergy 2005; 35:741-745.
31. Mah KW, Bjorksten B, Lee BW, et al. Distinct pattern of commensal gut microbiota in toddlers with eczema. Int Arch Allergy Immunol 2006; 140:157-163.
32. Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56:661-667.
33. Penders J, Stobberingh EE, Thijs C, et al. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy 2006; 36:1602-1608.
34. Suzuki S, Shimojo N, Tajiri Y, et al. Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clin Exp Allergy 2007; 37:506-511.
35. Moro G, Arslanoglu S, Stahl B, et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006; 91:814-819. This describes a clinical trial with interesting outcomes.
36. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:192-198. This was a large clinical intervention study showing a positive effect of probiotics and prebiotics in the prevention of atopic eczema.
37. Sokol H, Seksik P, Rigottier-Gois L, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:106-111.
38. Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53:685-693.
39. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55:205-211. In this outstanding investigation by metagenomic approach of the faecal flora in Crohn's disease the authors unveiled a marked reduction of biodiversity in patients in remission.
40. Scanlan PD, Shanahan F, O'Mahony C, Marchesi JR. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol 2006; 44:3980-3988.
41. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122:44-54.
42. Conte MP, Schippa S, Zamboni I, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006; 55:1760-1767.
43. Seksik P, Lepage P, de la Cochetiere MF, et al. Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA. J Clin Microbiol 2005; 43:4654-4658.
44. Bibiloni R, Mangold M, Madsen KL, et al. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006; 55:1141-1149.
45. Gophna U, Sommerfeld K, Gophna S, et al. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2006; 44:4136-4141.
46. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomized controlled pilot trial. Gut 2005; 54:242-249.
47. Casellas F, Borruel N, Torrejon A, et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 2007; 25:1061-1067.
48. Lindsay JO, Whelan K, Stagg AJ, et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 2006; 55:348-355.
49. Yamanaka T, Helgeland L, Farstad IN, et al. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J Immunol 2003; 170:816-822.
50. Mazmanian SK, Kasper DL. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 2006; 6:849-858. Excellent review on the tasks of the mucosal immune system in the gut for discriminating pathogen and nonpathogen microbia.
51. Demengeot J, Zelenay S, Moraes-Fontes MF, et al. Regulatory T cells in microbial infection. Springer Semin Immunopathol 2006; 28:41-50.
52. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199:971-979.
53. Venken K, Hellings N, Hensen K, et al. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J Neurosci Res 2006; 83:1432-1446.
54. Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363:608-615.
55. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004; 199:1679-1688.
56. Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease. Gastroenterology 2005; 128:1868-1878.
57. Holmen N, Lundgren A, Lundin S, et al. Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis 2006; 12:447-456.
58. Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clin Exp Allergy 2006; 36:402-425.
59. Rook GA, Brunet LR. Old friends for breakfast. Clin Exp Allergy 2005; 35:841-842.